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ABSTRACT 
Current study is intended to investigate the antimicrobial and antidiabetic potential of Bombax 
ceiba L. Antileishmanial potential was assessed via MTT colorimetric method while antifungal 
activities were found out through disc diffusion method. The antidiabetic potential was 
investigated by α-amylase inhibition assay. Considerable antifungal activity (in the range of 10-
12 mm ZOI) was demonstrated by CH: M extracts of both flower and stem bark, and CH extract 
of root bark against A. niger Whereas M: EA, AC extracts of leaf, EA extract of stem bark, NH, 
CH:E, M:EA extracts of root bark and NH extract of root wood exhibited the antifungal potential 
(ZOI from 10-12 mm) against  F. solani. The most potent α-amylase inhibitory activity was 
shown by EA extract of leaf part with 66.69 ± 0.95% inhibition (IC50 190 ± 4.5 µg/ml). Selected 
plant is a potential source of antileishmanial, antifungal and antidiabetic agents. This information 
can be further utilized for the purpose of bioactivity guided isolation of biologically active 
principles of B. ceiba L. 
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INTRODUCTION 
The antimicrobial properties of plants are 
known since ancient times, while efforts to 
validate these properties started from early 
1900s.Traditional approaches are being 
adopted against microbial diseases. 
Antimicrobial properties of various plants 
have been estimated previously. Evaluation 
of antimicrobial potential of folklore plants 
has attracted the attention of researchers 
(Dorman, 1999). The management of 
diabetes is a universal challenge because 
successful cure of this disease has not been 
discovered yet. Multiple medicines have 
been formulated but none of the patients 
have been completely cured from diabetes. 
Moreover, these medications produce 
various unwanted effects. Thus, an 
increasing trend has been found towards 
folklore plants. The traditional medicines 
have been found as potential candidates for 
management of diabetes (Malviya et al., 
2010). Undertaken study intends to 
investigate the antimicrobial and antidiabetic 
potential of a folklore plant, Bombax ceiba 
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L.“Bombax” (Greek word; silkworm) 
“ceiba” (silk cotton tree) is a medicinal plant 
locally called “Sumbal” in Pakistan (Family 
Bombacaceae). It is a fast growing, strong 
tree which attains about 40 m of height 
(Gupta , 2012; Sint et al., 2013). 
In December, it sheds all leaves and in 
January it blossoms into bright crimson 
flowers. It grows best in valleys and in 
regions where rainfall is about 60 to 450 cm 
annually (Rameshwar et al., 2014). B. ceiba 
L. is a tropical and subtropical tree native to 
South and East Asia, Indian subcontinent, 
western Africa and Northern Australia. It is 
naturally distributed in Myanmar, Pakistan, 
India, Taiwan, China, Moluccas, Philippine, 
Java, Borneo, Sulawesi, Lesser Sunda 
Island, and New Guinea (Sint et al., 2013). 
All old systems of medicine such as 
Ayurveda, Unani, Siddha and traditional 
Chinese system of medicine contain its 
marked traditional uses (Ravi et al., 2010).  
This study aims to provide scientific 
evidence for the profound background of 
ethnobotanical uses and also compare some 
vital chemical constituents present in 
various parts of B. ceiba L. Previously, the 
studies reported antidiabetic (Tiwari and 
Rana, 2015) antianemial (Kalita et al., 2015) 
hepatoprotective (Ravi et al., 2010), 
antilithiatic (Shelke et al., 2014), in vitro 
anti-inflammatory (Rameshwar et al., 2014), 
antimicrobial (Krishnaraju AV et al., 2005), 
hypotensive (Saleem et al., 2003) and 
antipyretic activities (Hossain et al., 2011) 
of B. ceiba L. In folklore medicine, it is 
utilized for nocturnal emission, blood 
purification, semen problems, over bleeding 
in menstruation, leucorrhoea, skin blemish, 
acne, pigmentation, weakness, wounds, 
improve breast milk, cold and cough 
(Rameshwar et al., 2014). 
METHODOLOGY 
Preparation of extracts 
Plant was collected and sorted to remove 
unwanted substances, rinsed with tap water 
and shade dried. The dried parts were 
pulverized separately by commercial miller 
to coarse powder. The sonication aided 
maceration technique was employed for 
extraction by using fourteen different 
solvents either alone or 1:1 combination. 
The accurately weighed plant powder (50 g) 
was soaked in 200 ml solvent using 
Erlenmeyer flask at room temperature for 72 
hrs with frequent agitation on ultrasonic bath 
(temperature 25°C, frequency 25 kHz). 
After 3 days, plant material was strained by 
muslin cloth and then filtered through 
Whatmann No. 1 filter paper. Finally, 
filtrates were concentrated (at room 
temperature) and dried in vacuum oven 
(Mermant, Germany). The crude extracts 
were then stored at -20°C. The different 
solvents employed for extraction process 
included; n-hexane (NH), chloroform (CH), 
ethyl acetate (EA), chloroform : methanol 
(CH:M), chloroform : ethanol (CH:E), 
acetone : ethyl acetate (AC:EA), methanol : 
ethyl acetate (M:EA), ethanol : ethyl acetate 
(E:EA), acetone (AC), methanol (M), 
ethanol (E), acetone : distilled water 
(AC:W), methanol : distilled water (M:W) 
and distilled water (W). 
Antimicrobial assays 
Antileishmanial assay 
The antileishmanial potential of crude 
extracts was assessed via MTT colorimetric 
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assay as documented previously by Zahra et 
al., (2017). 
Antifungal assay 
Antifungal potential of the test samples of B. 
ceiba was investigated via agar disc 
diffusion method Zahra et al., (2017). 
Antidiabetic assay 
α-Amylase inhibition assay 
Antidiabetic potential of test extracts was 
determined by α-amylase inhibition assay 
following the standard protocol with minor 
modifications (Nasir et al., 2017). 
RESULTS AND DISCUSSION 
Leishmaniasis is spread through a vector, 
sand fly (Durrani et al., 2012) and has a high 
annual incidence of cutaneous (1–1.5 
million cases) and visceral leishmaniasis 
(500,000 cases) (Desjeux et al., 2004). 
Leishmaniasis is endemic in 88 countries 
(Khan et al., 2011) including Pakistan, India, 
Afghanistan and Sudan (Murray et al., 
2005).  Therefore, the screening was 
performed, in which W extract of leaf 
exhibited significant antileishmanial activity 
with 80 ± 3.5% mortality at 20 μg/ml 
concentration with an IC50 3.5 ± 0.23 μg/ml. 
The standard used was amphotericin B (IC50 
0.01 ± 0.001 μg/ml) at final concentration of 
0.33 μg/ml. All other extracts were found to 
be inactive except stem wood’s M and AC 
extracts which showed some antileishmanial 
activity with 55 ± 2.5 and 50 ± 2.1% 
mortality respectively. The result depicts 
that the compounds with most potent 
activity are concentrated in the most polar 
extract i.e. water. Antileishmanial capability 
of different solvent extracts of B. ceiba L. 
was assessed for the first time according to 
the best of our knowledge. So, this 
information should be utilized for further 
isolation and characterization of pure 
compounds with potential to develop 
antileishmanial drugs in future. 
The antifungal potential for B. ceiba L. was 
explored via disc diffusion method. The 
results demonstrated that extract of B. ceiba 
L. showed potential activity against the 
tested fungal strains. Considerable 
antifungal activity (in the range of 10-12 
mm ZOI) was demonstrated by CH:M 
extracts of both flower and stem bark, and 
CH extract of root bark against A. niger. 
Whereas against F. solani, M:EA, AC 
extracts of leaf, EA extract of stem bark, 
NH, CH:E, M:EA extracts of root bark and 
NH extract of root wood exhibited the 
antifungal potential (ZOI from 10-12 mm). 
However a few extracts (namely; NH, CH, 
EA, E:EA, M and W) of root wood part 
exclusively showed activity against A. 
fumigatus strain. No activity was observed 
against Mucor sp., and A. flavus strains. In 
literature, the moderate (10-14 mm ZOI) 
antifungal activity has been reported against 
Candida albicans and A. niger by methanol, 
n-hexane and chloroform root extracts of B. 
ceiba (Islam et al., 2011). The significant 
potential of subject plant can be exploited as 
a vital source of antifungal leads.  
The adverse effects associated with insulin 
and oral hypoglycemics have led researchers 
to focus on the alternative sources of new 
antidiabetic agents (Patel et al., 2012). The 
84 extracts of B. ceiba L. were therefore 
screened for α-amylase inhibition activity 
and results were shown as percent α-
amylase inhibition (Figure 1). 
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Figure 1: Comparison of α-amylase inhibition assay of different parts of B. ceiba L. crude 
extracts. The IC50 of acarbose (positive control) = 33.73 ± 0.12 µg/ml. The values are 
presented as mean ± standard deviation (n = 3). 
The results showed that the plant exhibited 
considerable antidiabetic activity. The most 
potent α-amylase inhibitory activity was 
displayed by EA extract of leaf part with 
66.69 ± 0.95% inhibition (IC50 190 ± 4.5 
µg/ml). Moderate α-amylase inhibitory 
activity (in the range of 35-55% inhibition) 
was demonstrated by the non-polar (NH, CH 
and EA) extracts of all parts of the plant. 
While almost no α-amylase inhibitory 
activity was observed in polar (M:W and W) 
extracts of all parts of the plant. Moreover, 
the extracts of moderate polarity exhibited 
either none or very less α-amylase inhibitory 
activity as compared to their non-polar 
counterparts. It indicates that compounds 
which have α-amylase inhibitory potential 
are congregated in non-polar extracts of the 
plant. Contrary to above, an in vivo 
hypoglycemic activity has been reported in 
Sprague-Dawley rats from shamimin, a C-
flavonol glucoside, obtained from aqueous 
and methanolic extracts of leaf part of B. 
ceiba (Saleem R et al., 1999). This shows 
that the above investigation is targeting 
hypoglycemic effect by some other 
mechanism which is different from α-
amylase inhibition. This information can be 
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further utilized for large scale extraction 
studies for isolation of compounds with 
antidiabetic potential.  
CONCLUSION 
Selected plant was found to possess 
antimicrobial and antidiabetic potential. 
Bioassay guided isolation should be carried 
to isolate bioactive leads. Plant based green 
synthesis of nanoparticles is recommended 
as revealed by Nazli et al., (2018). 
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